Online inquiry

IVTScrip™ mRNA-Human ANKUB1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21541MR)

This product GTTS-WK21541MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKUB1 protein. This product can be used in Ciliated epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001144960.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 389161
UniProt ID A6NFN9
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKUB1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21541MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK27337MR IVTScrip™ mRNA-Human APOLD1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA APOLD1
GTTS-WK22512MR IVTScrip™ mRNA-Human APLP2, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA APLP2
GTTS-WK10180MR IVTScrip™ mRNA-Human AFAP1L2, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA AFAP1L2
GTTS-WK21156MR IVTScrip™ mRNA-Human AMOTL1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AMOTL1
GTTS-WK17355MR IVTScrip™ mRNA-Human ANTXR1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANTXR1
GTTS-WK26510MR IVTScrip™ mRNA-Human ARHGEF16, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARHGEF16
GTTS-WK11939MR IVTScrip™ mRNA-Human ADGRE5, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADGRE5
GTTS-WK26881MR IVTScrip™ mRNA-Human ARRDC3-AS1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARRDC3-AS1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →